Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
- Resource Type
- Correspondence
- Authors
- Fendler, Annika; Shepherd, Scott T C; Au, Lewis; Wu, Mary; Harvey, Ruth; Schmitt, Andreas M; Tippu, Zayd; Shum, Benjamin; Farag, Sheima; Rogiers, Aljosja; Carlyle, Eleanor; Edmonds, Kim; Del Rosario, Lyra; Lingard, Karla; Mangwende, Mary; Holt, Lucy; Ahmod, Hamid; Korteweg, Justine; Foley, Tara; Barber, Taja; Emslie-Henry, Andrea; Caulfield-Lynch, Niamh; Byrne, Fiona; Deng, Daqi; Kjaer, Svend; Song, Ok-Ryul; Queval, Christophe; Kavanagh, Caitlin; Wall, Emma C; Carr, Edward J; Caidan, Simon; Gavrielides, Mike; MacRae, James I; Kelly, Gavin; Peat, Kema; Kelly, Denise; Murra, Aida; Kelly, Kayleigh; O'Flaherty, Molly; Shea, Robyn L; Gardner, Gail; Murray, Darren; Yousaf, Nadia; Jhanji, Shaman; Tatham, Kate; Cunningham, David; Van As, Nicholas; Young, Kate; Furness, Andrew J S; Pickering, Lisa; Beale, Rupert; Swanton, Charles; Gandhi, Sonia; Gamblin, Steve; Bauer, David L V; Kassiotis, George; Howell, Michael; Nicholson, Emma; Walker, Susanna; Larkin, James; Turajlic, Samra
- Source
- In The Lancet 5-11 March 2022 399(10328):905-907
- Subject
- Analysis and Interpretation
Correspondence
- Language
- ISSN
- 0140-6736